Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.912
5 Year Impact Factor:
2.947
Subscribe to this Journal
Call for Editors
Book Proposal
Join Editorial Board
New Journal Proposal
Become a Reviewer
Become an Executive Guest Editor
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 15
- Number 7
Meet Our Editorial Board Member:
,
15
(
7
):
543
Ingunn Holen
DOI:
10.2174/156800961507150828193234
Permissions
Order Reprints
Order Eprints
Nanobiotechnological Approaches to Overcome Drug Resistance in Breast Cancer
,
15
(
7
):
544
- 562
Peyman Ranji, Zahra Heydari and Ali Mohammad Alizadeh
DOI:
10.2174/1568009615666150706102842
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors
,
15
(
7
):
563
- 574
Alessandra Mingione, Chiara Verdelli, Annalisa Terranegra, Laura Soldati and Sabrina Corbetta
DOI:
10.2174/1568009615666150602143041
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection
,
15
(
7
):
575
- 592
Chuanwen Lu, Jose A. Figueroa, Zhongwei Liu, Venu Konala, Amardeep Aulakh, Rashmi Verma, Everardo Cobos, Maurizio Chiriva-Internati and Weimin Gao
DOI:
10.2174/156800961507150828223554
View Abstract
中文摘要
Permissions
Order Reprints
Order Eprints
View Abstract
中文摘要
Current Drug Targets for Thymic Neoplasms
,
15
(
7
):
593
- 603
Xiao-Ling Xu and Wei-Min Mao
DOI:
10.2174/1568009615666150616124155
View Abstract
中文摘要
Permissions
Order Reprints
Order Eprints
View Abstract
中文摘要
Aerosol Delivery in the Treatment of Lung Cancer
,
15
(
7
):
604
- 612
Chiara Storti, Valentino Le Noci, Michele Sommariva, Elda Tagliabue, Andrea Balsari and Lucia Sfondrini
DOI:
10.2174/1568009615666150602143751
View Abstract
中文摘要
Permissions
Order Reprints
Order Eprints
View Abstract
中文摘要
The JNK Signaling Pathway Is a Novel Molecular Target for S-Propargyl- L-Cysteine, a Naturally-Occurring Garlic Derivatives: Link to Its Anticancer Activity in Pancreatic Cancer In Vitro and In Vivo
,
15
(
7
):
613
- 623
Wei Wang, Jianwen Cheng and Yizhun Zhu
DOI:
10.2174/1568009615666150602143943
View Abstract
中文摘要
Permissions
Order Reprints
Order Eprints
View Abstract
中文摘要
An Innovative Fluorescent Semi-quantitative Methylation-specific PCR Method for the Determination of MGMT Promoter Methylation is Reflecting Intra-tumor Heterogeneity
,
15
(
7
):
624
- 640
Aurelia Nguyen, Michele Legrain, Georges Noel, Andres Coca, Nicolos Meyer(EA), Roland Schott, Christelle Lasthaus, Marie Pierrette Chenard, Marie Pierre Gaub, Jean Marc Lessinger, Dominique Guenot and Natacha Entz-Werle
DOI:
10.2174/1568009615666150629130139
View Abstract
中文摘要
Permissions
Order Reprints
Order Eprints
View Abstract
中文摘要
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy